Dr. Mays received his bachelor of sciences from Carnegie Mellon, his PhD from Stanford University in molecular and cellular physiology, and subsequently studied as a visiting scholar at the University of Utrecht, the Netherlands, and the Weizmann Institute in Rehovot, Israel and as a post-doctoral fellow at the University of California, San Francisco. Since co-founding Athersys in 1995, Dr. Mays has directed the drug discovery applications of Athersys' cell biological platform technologies. Currently, Dr. Mays is the senior director of Regenerative Medicine and is focused on the development of Athersys' novel human stem cell product MultiStem® and its applications in Regenerative Medicine and drug discovery, with a specific focus on injuries and diseases affecting the central nervous system.